Drugs / COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05411471 | Jun 2022 → Jun 2023 | COVID-19 | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05411471 ↗ |
| Modality | Vaccine | “booster vaccine of using one or two doses of COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain” NCT05411471 ↗ |